chr4-107931653-C-T
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2
The NM_183075.3(CYP2U1):c.10C>T(p.Pro4Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00063 in 1,259,394 control chromosomes in the GnomAD database, including 7 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Consequence
NM_183075.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -20 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.00331 AC: 502AN: 151728Hom.: 3 Cov.: 33
GnomAD3 exomes AF: 0.00235 AC: 3AN: 1274Hom.: 0 AF XY: 0.00135 AC XY: 1AN XY: 740
GnomAD4 exome AF: 0.000263 AC: 291AN: 1107558Hom.: 4 Cov.: 30 AF XY: 0.000239 AC XY: 126AN XY: 527768
GnomAD4 genome AF: 0.00331 AC: 503AN: 151836Hom.: 3 Cov.: 33 AF XY: 0.00340 AC XY: 252AN XY: 74212
ClinVar
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Nov 01, 2022 | CYP2U1: PP2, BS1, BS2 - |
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Spastic paraplegia Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 29, 2024 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at